Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia (Anew)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03230864
Recruitment Status : Recruiting
First Posted : July 27, 2017
Last Update Posted : October 12, 2018
Information provided by (Responsible Party):
H. Lundbeck A/S

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 2020
  Estimated Study Completion Date : September 2020